Compounds > anastrozole

anastrozole and finasteride

anastrozole has been researched along with finasteride in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Bellavance, E; Luu-The, V; Poirier, D1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Kurokawa, K; Mamiya, Y; Okazaki, H; Ono, Y; Onuma, E; Suzuki, K; Suzuki, T; Takanashi, H; Yamanaka, H1
Campelo, AE; Cutini, PH; Massheimer, VL1

Reviews

1 review(s) available for anastrozole and finasteride

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for anastrozole and finasteride

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
    Journal of medicinal chemistry, 2009, Dec-10, Volume: 52, Issue:23

    Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity

2009
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy.
    The Prostate, 1998, Oct-01, Volume: 37, Issue:2

    Topics: Anastrozole; Animals; Aromatase; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dogs; Enzyme Inhibitors; Finasteride; Male; Nitriles; Oxidoreductases; Prostate; Prostatic Hyperplasia; Testosterone; Triazoles

1998
Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol.
    Steroids, 2012, Volume: 77, Issue:11

    Topics: 5-alpha Reductase Inhibitors; Anastrozole; Androgen Antagonists; Animals; Aorta; Aromatase Inhibitors; Cell Adhesion; Cell Proliferation; Dose-Response Relationship, Drug; Endothelial Cells; Estradiol; Estrogen Antagonists; Female; Finasteride; Flutamide; Fulvestrant; Monocytes; Myocytes, Smooth Muscle; Nitric Oxide; Nitriles; Rats; Rats, Wistar; Testosterone; Triazoles

2012